GeneDx Holdings annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
GeneDx Holdings Depreciation & Amortization Growth & History (WGS)
GeneDx Holdings's depreciation and amortization was $9.6M for fiscal 2025.
View full GeneDx Holdings company overviewGeneDx Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.6M | $1.7M | +21.52% |
| 2024 | 2024-12-31 | $7.9M | −$11.8M | −59.90% |
| 2023 | 2023-12-31 | $19.7M | −$30.3M | −60.60% |
| 2022 | 2022-12-31 | $50.0M | $28.2M | +129.28% |
| 2021 | 2021-12-31 | $21.8M | $10.1M | +85.84% |
| 2020 | 2020-12-31 | $11.7M | $5.3M | +83.14% |
| 2019 | 2019-12-31 | $6.4M | — | — |
GeneDx Holdings quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.1M | $800,000 | +34.78% |
| Q1 2026 | 2026-03-31 | $2.7M | $500,000 | +22.73% |
| Q4 2025 | 2025-12-31 | $6.9M | — | — |
| Q3 2025 | 2025-09-30 | $2.4M | −$52,000 | −2.15% |
| Q2 2025 | 2025-06-30 | $2.3M | $588,000 | +34.35% |
| Q1 2025 | 2025-03-31 | $2.2M | $458,000 | +26.29% |
| Q3 2024 | 2024-09-30 | $2.4M | −$2.7M | −53.12% |
| Q2 2024 | 2024-06-30 | $1.7M | −$5.1M | −74.92% |
| Q1 2024 | 2024-03-31 | $1.7M | −$3.4M | −66.04% |
| Q3 2023 | 2023-09-30 | $5.2M | −$1.8M | −26.15% |
| Q2 2023 | 2023-06-30 | $6.8M | $199,000 | +3.00% |
| Q1 2023 | 2023-03-31 | $5.1M | −$673,000 | −11.60% |
| Q3 2022 | 2022-09-30 | $7.0M | $1.5M | +27.39% |
| Q2 2022 | 2022-06-30 | $6.6M | $1.0M | +17.94% |
| Q1 2022 | 2022-03-31 | $5.8M | $901,000 | +18.38% |
| Q3 2021 | 2021-09-30 | $5.5M | $2.4M | +79.03% |
| Q2 2021 | 2021-06-30 | $5.6M | — | — |
| Q1 2021 | 2021-03-31 | $4.9M | — | — |
| Q3 2020 | 2020-09-30 | $3.1M | — | — |
GeneDx Holdings depreciation and amortization trends
Over the last five fiscal years, GeneDx Holdings's depreciation and amortization decreased from $11.7M to $9.6M, a change of −$2.1M. The latest reported quarter, Q2 2026, shows $3.1M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings source filings ↗